Sign Up
Stories
University of Basel Delivers Revolutionary Treatment for Cartilage Lesions and Osteoarthritis
Share
Artificial Disc Market Set for Rapid Exp...
Axial Spondyloarthritis Market Projectio...
Bone Grafts and Substitutes Market Growt...
Bioengineering Human Vein Implants Innov...
Curiteva Appoints Medical Device Veteran
Osteoporosis Scanning Crisis
Overview
API
The University of Basel and the University Hospital Basel have successfully delivered the first biological implants for the treatment of cartilage lesions and osteoarthritis in humans. The revolutionary method called Nasal Chondrocyte Tissue-Engineered Cartilage (N-TEC) involves extracting cartilage from the nasal septum, growing it in the lab, and implanting it in the damaged joint. The team has shown promising results, with patients experiencing pain relief and improved ability to perform daily activities post-treatment. The trials are expanding to address cartilage defects in other joints.
Ask a question
How does the N-TEC procedure differ from other cartilage regeneration techniques?
What are the next steps in the development and implementation of the N-TEC method?
What are the potential benefits of the N-TEC method compared to traditional cartilage implantation methods?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Aug 2023
Sep 2023
Oct 2023
Coverage